rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1994-11-15
|
pubmed:abstractText |
Our purpose was to evaluate the impact of antepartum administration of corticosteroids on the course of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in pregnancies at 24 to 37 weeks' gestation.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0002-9378
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
171
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1148-53
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7943088-Adolescent,
pubmed-meshheading:7943088-Adult,
pubmed-meshheading:7943088-Alanine Transaminase,
pubmed-meshheading:7943088-Analysis of Variance,
pubmed-meshheading:7943088-Dexamethasone,
pubmed-meshheading:7943088-Discriminant Analysis,
pubmed-meshheading:7943088-Female,
pubmed-meshheading:7943088-HELLP Syndrome,
pubmed-meshheading:7943088-Humans,
pubmed-meshheading:7943088-L-Lactate Dehydrogenase,
pubmed-meshheading:7943088-Linear Models,
pubmed-meshheading:7943088-Multivariate Analysis,
pubmed-meshheading:7943088-Platelet Count,
pubmed-meshheading:7943088-Pregnancy,
pubmed-meshheading:7943088-Pregnancy Trimester, Second,
pubmed-meshheading:7943088-Pregnancy Trimester, Third,
pubmed-meshheading:7943088-Prospective Studies
|
pubmed:year |
1994
|
pubmed:articleTitle |
Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP)
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson 39216-4505.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|